Discover
NVAX
Novavax, Inc.
9.46
2 x 8.10
1 x 11.50
bid
ask
+
0.04
0.42%
2 @ 06:18 AM
9.43 -0.03 (0.32%)
| Ytd | 40.77% | |
| 1y | 39.94% |
9.29
day range
9.64
6.20
52 week range
11.97
| Open | 9.37 | Prev Close | 9.42 | Low | 9.29 | High | 9.64 | Mkt Cap | 1.56B |
| Vol | 4.43M | Avg Vol | 4.74M | EPS | -0.56 | P/E | N/A | Forward P/E | -17.43 |
| Beta | 2.41 | Short Ratio | 9.14 | Inst. Own | 69.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 9.14 | 200-d Avg | 8.52 | 1yr Est | 14.11 |
| Income Statement | |||
| Total Revenue | 139.51M | ||
| Revenues (USD) | 139.51M | ||
| Cost of Revenue | 30.70M | ||
| Gross Profit | 108.82M | ||
| Operating Expenses | 124.25M | ||
| Research and Development Expense | 95.47M | ||
| Selling, General and Administrative Expense | 28.78M | ||
| Operating Income | -15.43M | ||
| Interest Expense | 4.90M | ||
| Income Tax Expense | 985.00K | ||
| Net Income | -9.49M | ||
| Net Income Common Stock | -9.49M | ||
| Net Income Common Stock (USD) | -9.49M | ||
| Consolidated Income | -9.49M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -3.60M | ||
| Earning Before Interest & Taxes (USD) | -3.60M | ||
| Weighted Average Shares | 163.28M | ||
| Weighted Average Shares Diluted | 163.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 228.36M | ||
| Cash and Equivalents (USD) | 228.36M | ||
| Investments | 561.97M | ||
| Investments Current | 561.97M | ||
| Trade and Non-Trade Receivables | 23.31M | ||
| Current Assets | 850.82M | ||
| Property, Plant & Equipment Net | 63.51M | ||
| Total Assets | 1.04B | ||
| Debt Current | 2.11M | ||
| Total Debt | 295.06M | ||
| Current Liabilities | 342.46M | ||
| Debt Non-Current | 292.95M | ||
| Total Liabilities | 1.19B | ||
| Accumulated Retained Earnings (Deficit) | -4.58B | ||
| Accumulated Other Comprehensive Income | -5.07M | ||
| Shareholders Equity | -144.76M | ||
| Shareholders Equity (USD) | -144.76M | ||
| Assets Non-Current | 192.35M | ||
| Total Debt (USD) | 295.06M | ||
| Deferred Revenue | 448.05M | ||
| Goodwill and Intangible Assets | 112.89M | ||
| Inventory | 11.46M | ||
| Liabilities Non-Current | 845.46M | ||
| Trade and Non-Trade Payables | 16.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.06M | ||
| Net Cash Flow from Financing | 37.67M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.13M | ||
| Capital Expenditure | -1.27M | ||
| Issuance (Purchase) of Equity Shares | -8.16M | ||
| Issuance (Repayment) of Debt Securities | 45.83M | ||
| Net Cash Flow from Investing | -28.36M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -66.84M | ||
| Net Cash Flow from Operations | -32.42M | ||
| Effect of Exchange Rate Changes on Cash | -18.00K | ||
| Share Based Compensation | 7.72M | ||